Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload.

Frontiers in pharmacology·2026
Same author

Deep-sequencing-guided library screening and profiling of AAV capsids in the primate retina.

Molecular therapy. Advances·2026
Same author

Development of In Vitro Potency Assays for Gene Therapy Products Targeting cGMP-Related Retinopathies.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

STARR-CRAAVT: A platform to identify cell type-specific regulatory elements for next-generation gene therapy.

iScience·2026
Same author

TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition.

The EMBO journal·2026
Same author

Impaired touch sensation on hairy skin in HCN3-deficient mice.

Frontiers in neuroscience·2026

Related Experiment Video

Updated: May 9, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Gene replacement therapy for retinal CNG channelopathies.

Christian Schön1, Martin Biel, Stylianos Michalakis

  • 1Center for Integrated Protein Science Munich, CIPSM and Department of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstr 5-13, 81377, Munich, Germany.

Molecular Genetics and Genomics : MGG
|July 18, 2013
PubMed
Summary

Cyclic nucleotide-gated (CNG) channels are crucial for vision. Mutations cause retinal diseases, but gene therapy shows promise for treating these conditions.

More Related Videos

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Related Experiment Videos

Last Updated: May 9, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Visual phototransduction depends on cyclic nucleotide-gated (CNG) channels in photoreceptor outer segments.
  • These channels convert light-induced cyclic guanosine 3'-5'-monophosphate (cGMP) level changes into electrical signals for visual processing.
  • Distinct CNG channel compositions exist in rod (CNGA1/CNGB1) and cone (CNGA3/CNGB3) photoreceptors.

Purpose of the Study:

  • To review human diseases and animal models associated with CNG channelopathies.
  • To summarize preclinical gene therapy studies for these conditions.
  • To discuss the efficacy and translational potential of gene therapeutic approaches.

Main Methods:

  • Review of scientific literature on CNG channelopathies and gene therapy.
  • Analysis of preclinical studies using adeno-associated viral vectors (AAVs).
  • Evaluation of gene therapy efficacy and translational potential.

Main Results:

  • Mutations in CNG channel subunits lead to severe retinal degenerative diseases like retinitis pigmentosa and achromatopsia.
  • Preclinical gene therapy studies using AAV vectors show potential for treating these channelopathies.
  • Gene therapy approaches are being evaluated for their efficacy and clinical applicability.

Conclusions:

  • CNG channelopathies represent a significant cause of untreatable retinal diseases.
  • Gene therapy, particularly using AAV vectors, offers a promising therapeutic strategy.
  • Further research is needed to optimize and translate these gene therapeutic approaches for clinical use.